A two-circRNA signature predicts tumour recurrence in clinical non-functioning pituitary adenoma

Clinical non-functioning pituitary adenoma (NFPA) accounts for >30% of all pituitary adenomas, and the recurrence rate is notably high. The ability to predict tumour recurrence during initial surgery will aid in determining if adjunctive therapy is required to reduce recurrence. With the aim of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jing, Wang, Zhuang, Miao, Yazhou, Shen, Yutao, Li, Mingxuan, Gong, Lei, Wang, Hongyun, He, Yue, Gao, Hua, Liu, Qian, Li, Chuzhong, Zhang, Yazhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278571/
https://www.ncbi.nlm.nih.gov/pubmed/30542712
http://dx.doi.org/10.3892/or.2018.6851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278571/
https://www.ncbi.nlm.nih.gov/pubmed/30542712
http://dx.doi.org/10.3892/or.2018.6851

Ejemplares similares